Wragge Lawrence Graham & Co
- Litigation / Dispute Resolution (266)
- Company/Commercial (133)
- Employment (120)
- Regulatory and compliance (73)
- Real Estate (71)
- Corporate (56)
- Banking / Finance (54)
- Financial services (50)
- Intellectual Property (46)
- Pensions (35)
- Tax (33)
- Construction (31)
- Information Technology (27)
- Insolvency & restructuring (27)
- Funds (22)
- Energy (20)
- Planning (20)
- Crime (16)
- Environment (16)
- Family (16)
- Healthcare (16)
- Public Sector/Local Authority (14)
- Commodities (13)
- Competition/EU (12)
- Insurance/reinsurance (12)
- Pharma/Biotech (12)
- Human Rights (10)
- Transport (Including aviation and shipping) (9)
- Media/Entertainment/Sport (8)
- Personal tax / Trusts (8)
- Private Equity (8)
- Professional Indemnity/Negligence (8)
- Business Tax (6)
- Privacy and reputation (4)
- In-House (3)
- PPP/PFI/Commercial projects (3)
- Clinical/Medical Negligence (2)
- Personal Injury (2)
- Private Client (2)
- Telecoms (2)
- Immigration (1)
- Public Sector Watch (1)
- Travel and Tourism (1)
Sort By: Newest first | Oldest first
Arnold J has delivered a solution to the issue of a patent with claims in the ‘Swiss form’ but this is unlikely to be the last word in the saga. Life sciences companies – watch this space.
Last year there were positive and interesting developments regarding French capital gains tax applicable to non-French tax residents. News that these developments are now confirmed will be welcomed by many.
Latest developments that might affect your business and what you can do about them.
If you think that the Housing Grants Act makes payment (or not) clear, keep reading for the latest case...
You may be forgiven for thinking that as of 27 February 2015, the Housing Grants, Construction and Regeneration Act 1996 (the Act), has little effect in terms of its payment and adjudication provisions.
Arnold J does battle again with the complexities of European Trade Mark law in a dispute about the trademark SUPREME for foodstuffs for rabbits and other small animals.
Wragge Lawrence Graham & Co’s dedicated insolvency litigation team bring you their monthly update on the cases and issues affecting the insolvency and fraud investigation industry.
Greg Standing looks at the different factors contributing to growth in UK car sales, the impact of PCP products on the industry and both the challenges and opportunities facing the industry in the future.
Wragge Lawrence Graham & Co’s non-contentious engineering and construction experts provide their top 10 tips for executing documents.
Parallel imports: when it is permissible to rebrand goods to the trademark used in the importing EU member state?
The Court of Appeal has returned its judgment in parallel imports case Speciality European Pharma v Doncaster Pharmaceuticals.
Wragge Lawrence Graham & Co’s finance litigation experts bring you the latest on the cases and issues affecting the lending industry.
The new public sector procurement directive becomes law in the UK (except Scotland) on 26 February 2015.
As the DPR awaits European Council approval, how is the Council’s vision for the new rules developing?
Late payments and “standing up for small businesses” have emerged as key political issues for most of the main political parties in the run up to the UK general election.
This alert provides a guide for trustees embarking on a review of the security of their DC assets.
Wragge Lawrence Graham & Co has reaffirmed its public sector credentials with an appointment to the national legal services procurement framework for Local Government Pension Scheme Funds.
A new tribunal case throws fresh light on the need to take a careful and considered approach to real estate dealings – and not to rely on an overly-mechanistic interpretation of VAT law and HMRC guidance.
The Code of Good Practice on Incentive Exercises (the Code) was issued in June 2012 by an industry working group.
The Court of Appeal has confirmed Birss J’s finding that Genentech’s dosage regimen patent, concerning the monoclonal antibody which is the active ingredient in Herceptin, was obvious.
Arnold J refuses to strike out Warner-Lambert's claim: construction of Swiss form claims is an issue suitable for the Supreme Court
Arnold J has handed down a second decision in the dispute between Warner-Lambert and Actavis.
In a judgment dealing with the collapse of the Arch Cru funds the High Court has re-examined and clarified the law applying to investment managers.